Disease progression in sporadic inclusion body myositis: Observations in 78 patients

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Neurology

• Publication date

  2000-07-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.55.2.296PMID 10908910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens.

  1998cited by this paper
• Memory impairment in abstinent MDMA ("Ecstasy") users

  1998cited by this paper
• Inclusion body myositis and myopathies

  1997cited by this paper
• The therapeutic dilemma of inclusion body myositis

  1997cited by this paper
• Treatment of inclusion-body myositis with IVIg

  1997cited by this paper
• Pathology of Drug Abuse

  1997cited by this paper
• Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients

  1996cited by this paper
• Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users

  1996cited by this paper
• The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.

  1996cited by this paper
• Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

  1996cited by this paper
• Inclusion body myositis and myopathies

  1995cited by this paper
• Ragged Red Fibers in Normal Aging and Inflammatory Myopathy

  1995cited by this paper
• Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self- administration

  1994cited by this paper
• Inclusion Body Myositis: New Concepts

  1993cited by this paper
• Polymyositis, dermatomyositis and inclusion-body myositis.

  1991cited by this paper
• Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history

  1983cited by this paper
• Late-life chronic peripheral neuropathy of obscure nature.

  1982cited by this paper

• The clinical, serological and myopathological features of a cohort of Chinese patients with inclusion body myositis: a single center analysis

  2026cites this paper
• Whole‐body‐electro‐myostimulation for the care of inclusion body myositis—A case report

  2024cites this paper
• Current biomarkers in inclusion body myositis

  2024cites this paper
• Impact of sex, age at onset, and anti-cN1A antibodies on sporadic inclusion body myositis.

  2024cites this paper
• Intramyocardial fatty infiltration lesion in sporadic inclusion body myositis: a case report

  2024cites this paper
• Inclusion body myositis: Correcting mitochondfrial and lysosomal autophagy impairment as a potential therapeutic strategy.

  2024cites this paper
• Direct and indirect costs of idiopathic inflammatory myopathies in adults: A systematic review

  2024cites this paper
• Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis

  2023cites this paper
• Efficacy of endoscopic cricopharyngeal myotomy using a curved rigid laryngoscope in patients with sporadic inclusion body myositis: four retrospective case reviews

  2023cites this paper
• Autoimmune inflammatory myopathies.

  2023cites this paper
• Treatment of Severe Equinovarus Deformity Associated with Distal Myopathy

  2023cites this paper
• Atypical presentations of inclusion body myositis: Clinical characteristics and long‐term outcomes

  2022cites this paper
• Clinical heterogeneity based on race and sex within a large cohort of inclusion body myositis patients

  2022cites this paper
• Possible future avenues for myositis therapeutics: DM, IMNM and IBM.

  2022cites this paper
• Inclusion body myositis: Update on the diagnostic and therapeutic landscape

  2022cites this paper
• Motor impairment in a rare form of spastic paraplegia (Spoan syndrome): a 10-year follow-up

  2021cites this paper
• Epidemiology and Natural History of Inclusion Body Myositis

  2021influential citation
• Dysphagia in Inclusion Body Myositis, A Disease of the Elderly

  2021cites this paper
• Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithm

  2021cites this paper
• Inclusion body myositis: correlation of clinical outcomes with histopathology, electromyography and laboratory findings.

  2021cites this paper
• Survival and associated comorbidities in inclusion body myositis

  2021cites this paper
• Autoimmune Neurogenic Dysphagia

  2021cites this paper
• Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications

  2020cites this paper
• Prognostic factors and clinical outcome in a rare form of spastic paraplegia (Spoan syndrome): a 10-year follow-up CURRENT

  2020cites this paper
• The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis

  2020cites this paper
• Normas

  2020cites this paper
• Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis

  2019cites this paper
• Inclusion body myositis

  2019cites this paper
• Association Between TDP-43 and Mitochondria in Inclusion Body Myositis

  2019cites this paper
• Rehabilitation in Inclusion Body Myositis associated with human immunodeficiency virus (HIV) infection

  2019cites this paper
• Motor impairment in a rare form of spastic paraplegia (Spoan syndrome): a 10-year follow-up

  2019cites this paper
• CYLD dysregulation in pathogenesis of sporadic inclusion body myositis

  2019cites this paper
• Disability in idiopathic inflammatory myopathies: questionnaire-based study

  2019cites this paper
• Muscle‐dominant wild‐type TDP‐43 expression induces myopathological changes featuring tubular aggregates and TDP‐43‐positive inclusions

  2018cites this paper
• Differences in the pattern of muscular and extramuscular involvement in patients with inflammatory myopathy according to the clinical groups and specific autoantibodies

  2018cites this paper
• Autoimmune Myopathies: Updates on Evaluation and Treatment

  2018cites this paper
• Cytokine Profiling of Serum Allows Monitoring of Disease Progression in Inclusion Body Myositis

  2017cites this paper
• Burden of illness and healthcare resource use in United States patients with sporadic inclusion body myositis

  2017cites this paper
• Modeling functional decline over time in sporadic inclusion body myositis

  2017cites this paper
• Development of quantitative MRI as an outcome measure in Charcot-Marie-Tooth disease and inclusion body myositis

  2017cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• Demographic and clinical features of inclusion body myositis in north America

  2015cites this paper
• Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches.

  2015cites this paper
• Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis.

  2014cites this paper
• Idiopathic inflammatory myopathies.

  2014cites this paper
• Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials.

  2014cites this paper
• Clinical features of Japanese patients with inclusion body myositis.

  2014cites this paper
• Validity of the single limb heel raise test to predict lower extremity disablement in patients with sporadic inclusion body myositis

  2014cites this paper
• Dysphagia Due to Inclusion Body Myositis

  2014cites this paper
• A clinicopathological study of inclusion body myositis

  2014cites this paper
• Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials.

  2013cites this paper
• International Workshop : Inclusion Body Myositis , 2 – 4 December 2011 , Naarden , The Netherlands

  2013cites this paper
• Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features

  2013cites this paper
• [Inclusion body myositis--a rarely recognized disorder].

  2013cites this paper
• Inclusion body myositis: a case of bilateral extremity weakness.

  2013cites this paper
• Hilton-Jones independently of pathological features diagnosis of inclusion body myositis Clinical assessment determines the

  2013cites this paper
• Miositis con cuerpos de inclusión (forma esporádica)

  2012cites this paper
• Inclusion body myositis

  2012cites this paper
• Academic Year 2011-2012 Cancer associated myositis

  2012cites this paper
• Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies

  2012cites this paper
• Degenerative Neurological and Neuromuscular Disease Inclusion body myositis : therapeutic approaches

  2012cites this paper
• Inclusion body myositis: therapeutic approaches.

  2012cites this paper
• Knee extensor strength exhibits potential to predict function in sporadic inclusion‐body myositis

  2012cites this paper
• Muscle Aging, Inclusion-Body Myositis and Myopathies: Askanas/Muscle Aging, Inclusion-Body Myositis and Myopathies

  2012cites this paper
• Prognosis and prognostic factors in sporadic inclusion body myositis

  2012cites this paper
• A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities

  2012cites this paper
• C URRENT OPINION Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies

  2012cites this paper
• Inclusion body myositis: diagnosis, pathogenesis, and treatment options.

  2011cites this paper
• Inclusion body myositis: therapeutic approaches. A case report.

  2011cites this paper
• Sporadic inclusion-body myositis: clinical symptoms, physical findings, and diagnostic investigations

  2011cites this paper
• Miositis por cuerpos de inclusión: ¿una enfermedad subdiagnosticada?

  2011cites this paper
• A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.

  2011cites this paper
• Stance control orthosis trial in patients with inclusion body myositis

  2011cites this paper
• Gait patterns of patients with inclusion body myositis.

  2011cites this paper
• Inclusion Body Myositis

  2011cites this paper
• Update on sporadic inclusion body myositis.

  2011cites this paper
• Long-term observational study of sporadic inclusion body myositis.

  2011influential citation
• Chapter 14 – Targeted Treatment of the Idiopathic Inflammatory Myopathies

  2010cites this paper
• Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features

  2010cites this paper
• Disorders of Voluntary Muscle: Dystrophinopathies

  2010cites this paper
• 21 – Treatment and Management of Autoimmune Myopathies

  2010cites this paper
• B7-H1 Expression in Vestibular Schwannomas

  2010cites this paper
• Sporadic inclusion body myositis: an unsolved mystery.

  2009cites this paper
• [Inflammatory myopathies: diagnosis and classifications].

  2009cites this paper
• Etablierung eines kontrastmittelgestützten Ultraschallverfahrens zur Beurteilung der Skelettmuskelperfusion am Beispiel des M. biceps brachii des Menschen

  2008cites this paper
• Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM

  2008cites this paper
• Pathogenic mechanisms in idiopathic inflammatory myopathies

  2008cites this paper
• Dysphagia in Inclusion Body Myositis: Clinical Features, Management, and Clinical Outcome

  2008cites this paper
• Inclusion body myositis and HIV infection.

  2008cites this paper
• Dysphagia in Inclusion Body Myositis Features, Management, and Clinical Outcome

  2008cites this paper
• Autoimmune inflammatory myopathies.

  2007cites this paper
• The Effectiveness of an Individualized, Home-Based Functional Exercise Program for Patients With Sporadic Inclusion Body Myositis

  2007cites this paper
• Studies of immunopathogenic mecha- nisms and treatment of chronic, inflam - matory myopathies, myositis

  2007cites this paper
• Studies of immunopathogenic mechanisms and treatment of chronic, inflammatory myopathies, myositis

  2007cites this paper
• Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches.

  2007cites this paper
• Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients.

  2007cites this paper
• An unusual cause of pleural effusion.

  2006cites this paper
• Inclusion body myositis : a nationwide study

  2006cites this paper
• Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies

  2006cites this paper
• Inclusion body myositis: an underdiagnosed myopathy of older people.

  2006cites this paper